您的位置: 首页 > 农业专利 > 详情页

TRIMEGESTONE (TMG) DESTINEE AU TRAITEMENT DE LA NAISSANCE PREMATUREE
专利权人:
DIGNITY HEALTH
发明人:
GARFIELD, ROBERT E.,SHI, SHAO-QING,SHI, LEILI
申请号:
CA2813433
公开号:
CA2813433C
申请日:
2011.10.27
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
As disclosed herein, novel compositions including steroid hormones, such as trimegestone (TMG) and progesterone (P4), provide treatments for term and preterm labor with significant effects on the delay of delivery. Delay and block of delivery occurs when both P4 and TMG are administered late in gestation in pregnant rat and guinea pig animal models. TMG exhibits remarkable drug efficacy, achieving the same inhibition as P4, but at much lower doses. These hereto unknown effects of TMG on the processes of cervical ripening and uterine contraction provide a novel approach for extending pregnancy term, including reducing a likelihood of preterm and/or term labor, along with improved methods of administration. Other diseases and/or conditions may be treated with TMG, such as dysmenorrhea or luteal insufficiency for sustaining pregnancy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充